Israeli Biotech Firm Files for $75 Million Nasdaq IPO

Enzymotec, which makes additives, has 14 products and more in the pipeline.

Shelly Appelberg
Shelly Appelberg
Send in e-mailSend in e-mail
Shelly Appelberg
Shelly Appelberg

Comments